Ticker
PYC
Analysis
Pyc Therapeutics Limited (PYC) Stock Analysis
Pyc Therapeutics Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PYC.
Pyc Therapeutics Limited
Pyc Therapeutics Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PYC.
Stock profile
Asset type
Stock
Market cap
$996.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
AUD
Ticker listings
Pyc Therapeutics Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- PYC primary listing
- PYCXF
Latest Pyc Therapeutics Limited news
PKD - Initiation of Multiple Dose Clinical Trial
PKD - Initiation of Multiple Dose Clinical Trial
Presentation of Ophthalmology Clinical Trial Data at ARVO
Presentation of Ophthalmology Clinical Trial Data at ARVO
ADOA Program - SRC Approve Progression to Multi-Dose Study
ADOA Program - SRC Approve Progression to Multi-Dose Study
Completion of Retail Entitlement Offer
Completion of Retail Entitlement Offer
PKD Clinical Trial - Approval to Escalate Dosing
PKD Clinical Trial - Approval to Escalate Dosing
Research sections
Valuation
Review valuation context for Pyc Therapeutics Limited.
Future growth
Review future growth context for Pyc Therapeutics Limited.
Past performance
Review past performance context for Pyc Therapeutics Limited.
Financial health
Review financial health context for Pyc Therapeutics Limited.
Dividend
Review dividend context for Pyc Therapeutics Limited.
Management
Review management context for Pyc Therapeutics Limited.
Ownership
Review ownership context for Pyc Therapeutics Limited.
Other information
Review other information context for Pyc Therapeutics Limited.
Community
Review community context for Pyc Therapeutics Limited.